Cell Growth & Differentiation, Vol 3, Issue 5 279-289, Copyright © 1992 by American Association of Cancer Research

ARTICLES

Expression of the PAX2 gene in human fetal kidney and Wilms' tumor

MR Eccles, LJ Wallis, AE Fidler, NK Spurr, PJ Goodfellow and AE Reeve
Department of Biochemistry, University of Otago, Dunedin, New Zealand.

We have examined the pattern of expression of the human PAX2 gene in Wilms' tumors and human fetal kidney by Northern blot and in situ hybridization. Human PAX2 encodes a paired box-containing protein and has a high degree of homology with mouse and Drosophila paired box genes. In situ hybridization analysis reveals that PAX2 is expressed in nephrogenic structures in fetal kidney and also in Wilms' tumors. This pattern of expression suggests that PAX2 may have a role in differentiation of tissues in the kidney. In fetal kidney, PAX2 expression rapidly attenuates following the initial differentiation, but no evidence of attenuation was found in Wilms' tumors. The timing of PAX2 expression is restricted to fetal development, although high levels of expression were also observed in nephrogenic rests of residual normal juvenile kidney tissue adjacent to a Wilms' tumor. Nephrogenic rests are the presumptive precursors of Wilms' tumor but are not necessarily neoplastic. The failure of PAX2 expression to attenuate in Wilms' tumors and nephrogenic rests may be associated with events leading to the onset of Wilms' tumor. By somatic cell hybrid mapping, the PAX2 gene was localized to chromosome 10q22.1-q24.3, although this region has not previously been implicated in Wilms' tumor.

This article has been cited by other articles:

				V. Fonsato, S. Buttiglieri, M. Chiara Deregibus, B. Bussolati, E. Caselli, D. Di Luca, and G. Camussi PAX2 expression by HHV-8-infected endothelial cells induced a proangiogenic and proinvasive phenotype Blood, March 1, 2008; 111(5): 2806 - 2815. [Abstract] [Full Text] [PDF]

				J. Quinlan, M. Lemire, T. Hudson, H. Qu, A. Benjamin, A. Roy, E. Pascuet, M. Goodyer, C. Raju, Z. Zhang, et al. A Common Variant of the PAX2 Gene Is Associated with Reduced Newborn Kidney Size J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1915 - 1921. [Abstract] [Full Text] [PDF]

				D. Kim, M. Wang, Q. Cai, H. Brooks, and G. R. Dressler Pax Transactivation-Domain Interacting Protein Is Required for Urine Concentration and Osmotolerance in Collecting Duct Epithelia J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1458 - 1465. [Abstract] [Full Text] [PDF]

				T. Cohen, O. Loutochin, M. Amin, J.-P. Capolicchio, P. Goodyer, and R. Jednak PAX2 is reactivated in urinary tract obstruction and partially protects collecting duct cells from programmed cell death Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1267 - F1273. [Abstract] [Full Text] [PDF]

				V. Fonsato, S. Buttiglieri, M. C. Deregibus, V. Puntorieri, B. Bussolati, and G. Camussi Expression of Pax2 in Human Renal Tumor-Derived Endothelial Cells Sustains Apoptosis Resistance and Angiogenesis Am. J. Pathol., February 1, 2006; 168(2): 706 - 713. [Abstract] [Full Text] [PDF]

				S.-L. Zhang, B. Moini, and J. R. Ingelfinger Angiotensin II Increases Pax-2 Expression in Fetal Kidney Cells Via the AT2 Receptor J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1452 - 1465. [Abstract] [Full Text] [PDF]

				D. Edouga, B. Hugueny, B. Gasser, L. Bussieres, and K. Laborde Recovery after relief of fetal urinary obstruction: morphological, functional and molecular aspects Am J Physiol Renal Physiol, July 1, 2001; 281(1): F26 - F37. [Abstract] [Full Text] [PDF]

				E. Torban, M. R. Eccles, J. Favor, and P. R. Goodyer PAX2 Suppresses Apoptosis in Renal Collecting Duct Cells Am. J. Pathol., September 1, 2000; 157(3): 833 - 842. [Abstract] [Full Text] [PDF]

				S. Porteous, E. Torban, N.-P. Cho, H. Cunliffe, L. Chua, L. McNoe, T. Ward, C. Souza, P. Gus, R. Giugliani, et al. Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax21Neu +/- mutant mice Hum. Mol. Genet., January 1, 2000; 9(1): 1 - 11. [Abstract] [Full Text] [PDF]

				Y. Yang, C. Jeanpierre, G. R. Dressler, M. Lacoste, P. Niaudet, and M.-C. Gubler WT1 and PAX-2 Podocyte Expression in Denys-Drash Syndrome and Isolated Diffuse Mesangial Sclerosis Am. J. Pathol., January 1, 1999; 154(1): 181 - 192. [Abstract] [Full Text] [PDF]

				C. K. Stayner, H. E. Cunliffe, T. A. Ward, and M. R. Eccles Cloning and Characterization of the Human PAX2 Promoter J. Biol. Chem., September 25, 1998; 273(39): 25472 - 25479. [Abstract] [Full Text] [PDF]

				H. Chamberlin, R. Palmer, A. Newman, P. Sternberg, D. Baillie, and J. Thomas The PAX gene egl-38 mediates developmental patterning in Caenorhabditis elegans Development, January 10, 1997; 124(20): 3919 - 3928. [Abstract] [PDF]

				J. Favor, R. Sandulache, A. Neuhauser-Klaus, W. Pretsch, B. Chatterjee, E. Senft, W. Wurst, V. Blanquet, P. Grimes, R. Sporle, et al. The mouse Pax21Neu mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney PNAS, November 26, 1996; 93(24): 13870 - 13875. [Abstract] [Full Text] [PDF]

				M Torres, E Gomez-Pardo, G. Dressler, and P Gruss Pax-2 controls multiple steps of urogenital development Development, January 12, 1995; 121(12): 4057 - 4065. [Abstract] [PDF]

				G Ryan, V Steele-Perkins, J. Morris, F. Rauscher, and G. Dressler Repression of Pax-2 by WT1 during normal kidney development Development, January 3, 1995; 121(3): 867 - 875. [Abstract] [PDF]

				H. A. Franch, S. Sooparb, J. Du, and N. S. Brown A Mechanism Regulating Proteolysis of Specific Proteins during Renal Tubular Cell Growth J. Biol. Chem., May 25, 2001; 276(22): 19126 - 19131. [Abstract] [Full Text] [PDF]